These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 27722784

  • 1. Antiarrhythmic effect of the Ca2+-activated K+ (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation.
    Kirchhoff JE, Diness JG, Abildgaard L, Sheykhzade M, Grunnet M, Jespersen T.
    Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.
    Diness JG, Sørensen US, Nissen JD, Al-Shahib B, Jespersen T, Grunnet M, Hansen RS.
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):380-90. PubMed ID: 20562443
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium.
    Skibsbye L, Wang X, Axelsen LN, Bomholtz SH, Nielsen MS, Grunnet M, Bentzen BH, Jespersen T.
    J Cardiovasc Pharmacol; 2015 Aug 20; 66(2):165-76. PubMed ID: 25856531
    [Abstract] [Full Text] [Related]

  • 6. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G, Xue X, Gao C, Huang J, Qi D, Zhang Y, Dong JZ, Ma CS, Yan GX.
    J Am Heart Assoc; 2017 May 18; 6(5):. PubMed ID: 28522677
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
    Wirth KJ, Knobloch K.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb 18; 363(2):166-74. PubMed ID: 11218069
    [Abstract] [Full Text] [Related]

  • 9. Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels.
    Simó-Vicens R, Sauter DRP, Grunnet M, Diness JG, Bentzen BH.
    Eur J Pharmacol; 2017 May 15; 803():118-123. PubMed ID: 28322838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
    Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S.
    Circulation; 2003 Mar 18; 107(10):1440-6. PubMed ID: 12642367
    [Abstract] [Full Text] [Related]

  • 12. Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
    Ducroq J, Rouet R, Sallé L, Puddu PE, Repessé Y, Ghadanfar M, Ducouret P, Gérard JL.
    Eur J Pharmacol; 2006 Feb 27; 532(3):279-89. PubMed ID: 16480976
    [Abstract] [Full Text] [Related]

  • 13. The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.
    Skibsbye L, Diness JG, Sørensen US, Hansen RS, Grunnet M.
    J Cardiovasc Pharmacol; 2011 Jun 27; 57(6):672-81. PubMed ID: 21394037
    [Abstract] [Full Text] [Related]

  • 14. Dofetilide: a new class III antiarrhythmic agent.
    Al-Dashti R, Sami M.
    Can J Cardiol; 2001 Jan 27; 17(1):63-7. PubMed ID: 11173316
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological blockade of small conductance Ca2+-activated K+ channels by ICA reduces arrhythmic load in rats with acute myocardial infarction.
    Hundahl LA, Sattler SM, Skibsbye L, Diness JG, Tfelt-Hansen J, Jespersen T.
    Pflugers Arch; 2017 Jun 27; 469(5-6):739-750. PubMed ID: 28285409
    [Abstract] [Full Text] [Related]

  • 16. Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation.
    Carstensen H, Hesselkilde EZ, Haugaard MM, Flethøj M, Carlson J, Pehrson S, Jespersen T, Platonov PG, Buhl R.
    J Cardiovasc Electrophysiol; 2019 Apr 27; 30(4):596-606. PubMed ID: 30661267
    [Abstract] [Full Text] [Related]

  • 17. A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm.
    Tsikouris JP, Cox CD.
    Pharmacotherapy; 2001 Dec 27; 21(12):1514-29. PubMed ID: 11765303
    [Abstract] [Full Text] [Related]

  • 18. Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.
    Hashimoto N, Yamashita T, Tsuruzoe N.
    J Cardiovasc Pharmacol; 2008 Feb 27; 51(2):162-9. PubMed ID: 18287884
    [Abstract] [Full Text] [Related]

  • 19. Dofetilide (Tikosyn): a new drug to control atrial fibrillation.
    Saliba WI.
    Cleve Clin J Med; 2001 Apr 27; 68(4):353-63. PubMed ID: 11326815
    [Abstract] [Full Text] [Related]

  • 20. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K, Brendel J, Peukert S, Rosenstein B, Busch AE, Wirth KJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov 27; 366(5):482-7. PubMed ID: 12382079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.